[
  {
    "ts": null,
    "headline": "Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years.",
    "summary": "The  SPDR S&P Biotech  exchange-traded fund, which tracks a broad selection of biotech names, has shot up 8.9% since September 25, just more than a week ago.  The biotech run-up over the past week or so has been fueled by the same drug-pricing deal between  Pfizer  and President Donald Trump that set off a surge in Big Pharma share prices last Tuesday, along with a spate of acquisitions.  “Investors are naturally jittery, since prior rallies haven’t been sustained,” Cantor Fitzgerald analysts Josh Schimmer and Eric Schmidt wrote in a note on Friday.",
    "url": "https://finnhub.io/api/news?id=1a95ce3436e3b1e0658a591dd6e2f3d6e5e99a3906db105e7c009d2923a86cfc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759764780,
      "headline": "Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years.",
      "id": 136989354,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The  SPDR S&P Biotech  exchange-traded fund, which tracks a broad selection of biotech names, has shot up 8.9% since September 25, just more than a week ago.  The biotech run-up over the past week or so has been fueled by the same drug-pricing deal between  Pfizer  and President Donald Trump that set off a surge in Big Pharma share prices last Tuesday, along with a spate of acquisitions.  “Investors are naturally jittery, since prior rallies haven’t been sustained,” Cantor Fitzgerald analysts Josh Schimmer and Eric Schmidt wrote in a note on Friday.",
      "url": "https://finnhub.io/api/news?id=1a95ce3436e3b1e0658a591dd6e2f3d6e5e99a3906db105e7c009d2923a86cfc"
    }
  },
  {
    "ts": null,
    "headline": "My Top 5 Biotech Stocks Big Pharma Could Buy Next",
    "summary": "Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest to Big Pharma players.",
    "url": "https://finnhub.io/api/news?id=0615cc217ad0cd350a198a8133c50199b31af463e4f96ab378a062934e7cccc8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759757340,
      "headline": "My Top 5 Biotech Stocks Big Pharma Could Buy Next",
      "id": 136988239,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1146642361/image_1146642361.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest to Big Pharma players.",
      "url": "https://finnhub.io/api/news?id=0615cc217ad0cd350a198a8133c50199b31af463e4f96ab378a062934e7cccc8"
    }
  },
  {
    "ts": null,
    "headline": "Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Best Affordable Dividend Stocks to Buy Now. Bristol-Myers Squibb Company (NYSE:BMY) is an American pharmaceutical giant that operates in multiple countries and is based in New Jersey. In the second quarter, the company’s growth portfolio recorded double-digit sales, and at least seven products recorded more than […]",
    "url": "https://finnhub.io/api/news?id=fa5b79a7972e7cfdacc1cdde9a3f53603ac39e741e001b243e0bf9f938435731",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759720471,
      "headline": "Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks",
      "id": 136989671,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Best Affordable Dividend Stocks to Buy Now. Bristol-Myers Squibb Company (NYSE:BMY) is an American pharmaceutical giant that operates in multiple countries and is based in New Jersey. In the second quarter, the company’s growth portfolio recorded double-digit sales, and at least seven products recorded more than […]",
      "url": "https://finnhub.io/api/news?id=fa5b79a7972e7cfdacc1cdde9a3f53603ac39e741e001b243e0bf9f938435731"
    }
  }
]